Evidence map›Paper›PMID 24932260›Full record

ArticleOncology letters2014

Primary gastrointestinal stromal tumor of the prostate: A case report and literature review.

Sulai Liu, Qiuxia Yu, Weiqing Han, Lin Qi, Xiongbing Zu, Fuhua Zeng, Yu Xie, Jingshi Liu

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Primary prostatic extra-gastrointestinal stromal tumor causing giant prostatomegaly.Indian journal of urology : IJU : journal of the Urological Society of India
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Sulai LiuDepartment of Urology, Xiangya Hospital, The Central South University, Changsha, Hunan 410008, P.R. China ; Department of Urology, The Affiliated Tumor Hospital of Xiangya Medical School, The Central South University, Changsha, Hunan 410013, P.R. China.
Qiuxia YuDepartment of Rheumatology, Ningbo Medical Center Li Huili Hospital, Ningbo, Zhejiang 315040, P.R. China.
Weiqing HanDepartment of Urology, The Affiliated Tumor Hospital of Xiangya Medical School, The Central South University, Changsha, Hunan 410013, P.R. China.
Lin QiDepartment of Urology, Xiangya Hospital, The Central South University, Changsha, Hunan 410008, P.R. China.
Xiongbing ZuDepartment of Urology, Xiangya Hospital, The Central South University, Changsha, Hunan 410008, P.R. China.
Fuhua ZengDepartment of Urology, The Affiliated Tumor Hospital of Xiangya Medical School, The Central South University, Changsha, Hunan 410013, P.R. China.
Yu XieDepartment of Urology, The Affiliated Tumor Hospital of Xiangya Medical School, The Central South University, Changsha, Hunan 410013, P.R. China.
Jingshi LiuDepartment of Anesthesia, The Affiliated Tumor Hospital of Xiangya Medical School, The Central South University, Changsha, Hunan 410008, P.R. China.
Central South University · CNNingbo Medical Center Lihuili Hospital · CNXiangya Hospital Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extragastrointestinal stromal tumors (EGISTs) are relatively rare soft tissue neoplasms arising from the extra gastrointestinal tract. The current study presents a case of primary EGIST of the prostate observed in a 55-year-old male. Imaging studies showed a 10×10.5×9.5-cm prostate mass. On histological observation, the mass was separated from the rectum serosa and exhibited a high mitotic count (8/50 high-power fields). The results of immunohistochemical staining showed positive immunoreactivity for cluster of differentiation (CD)117 (c-kit), CD34 and DOG1 in the tumor. On mutation analysis, loss of heterozygosity of the c-kit gene was observed in the prostatic EGIST; however, the platelet-derived growth factor receptor-α (PDGFRA) gene was considered to be normal. Therefore, as EGIST of the prostate is rare, there is a requirement for the confirmation of the diagnosis to be based on immunohistochemistry and mutation analysis (of c-kit and PDGFRA).

Indexed as

c-kitextragastrointestinal stromal tumorsplatelet-derived growth factor receptor-αprostate

Identifiers

PMID24932260
PMCPMC4049718
OpenAlexW2106067251

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.